Education Library

Jacob Møller, MD, and Chuck Simonton, MD, discuss the DanGer Shock RCT and new data presented at TCT 2024.

The significance of the DanGer Shock trial lies in its milestone findings for cardiology, potentially reshaping patient care by establishing routine Impella use as a life-saving intervention for STEMI patients with shock.

A panel of interventional cardiologists discuss the DanGer Shock RCT results and the implications for AMICS patient management.

This overview article provides a framework for this series of articles. It addresses European recommendations and best practices for patient management and mechanical circulatory support (MCS) during high risk intervention, highlighting the following topics...

Babar Basir, DO, describes the importance of multidisciplinary care for patients with cardiogenic shock.

This article examines current evidence for the use of mechanical circulatory support (MCS) in cardiogenic shock and discusses how the scientific community can advance research in this area.

Babar Basir, D.O., discusses revascularization best practices in patients with cardiogenic shock.

Babar Basir, DO, highlights the increased use of acute mechanical circulatory support best practices since the National Cardiogenic Shock Initiative (NCSI) study.

Bessie Sycip presents OR and ICU best practice checklists for Impella 5.5® with SmartAssist®.

Jacob Møller, M.D., the principal investigator of the DanGer Shock trial, discusses the study results he presented at ACC 2024.

Babar Basir, DO, discusses the evolving understanding of the importance of unloading with Impella® in patients with cardiogenic shock. 

Babar Basir, DO, highlights trends and opportunities to improve outcomes using data from the National Cardiogenic Shock Initiative (NCSI) study.

Experts throughout Europe have contributed to this European Heart Journal supplement with articles discussing best practices for successfully managing mechanical circulatory support (MCS) in patients with cardiogenic shock.

Babar Basir, D.O., discusses the impact of the DanGer Shock RCT in clinical practice and looks into the future of AMI cardiogenic shock treatment and management.

This paper discusses the latest guidance for identifying patients with cardiogenic shock (CS) who are candidates for mechanical circulatory support (MCS).